secwatch.observer — SEC 8-K summary
======================================

Issuer:     Iterum Therapeutics plc (ITRMF)
CIK:        0001659323
Form:       8-K
Filed at:   2025-04-30T23:59:59+00:00
Accession:  0001193125-25-105148
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iterum Therapeutics announces $5M registered direct offering of ordinary shares and pre-funded warrants
--------------------------------------------------------------------------------

- Gross proceeds of $5.0M from sale of 5,555,556 shares/warrants at $0.90 each.
- Net proceeds ~$4.2M after fees; H.C. Wainwright acting as placement agent.
- Funding to support pre-commercialization of ORLYNVAH and strategic process, cash runway into 2026.
- Offering expected to close April 30, 2025, subject to customary conditions.
- Pre-funded warrants exercisable at $0.01 per share with 9.99% beneficial ownership cap.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659323/000119312525105148/0001193125-25-105148-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659323/000119312525105148/d803323d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-105148

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer